These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11967790

  • 21. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    Böhm M.
    Am J Cardiol; 2007 Aug 06; 100(3A):38J-44J. PubMed ID: 17666197
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II receptor blockers: novel therapy for heart failure?
    Munger MA, Furniss SM.
    Pharmacotherapy; 1996 Aug 06; 16(2 Pt 2):59S-68S. PubMed ID: 8668607
    [Abstract] [Full Text] [Related]

  • 23. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense?
    Hennig L.
    Clin Nephrol; 2002 Jul 06; 58 Suppl 1():S7-11. PubMed ID: 12227730
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun 06; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 25. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
    Weber MA.
    Rev Cardiovasc Med; 2002 Jun 06; 3(4):183-91. PubMed ID: 12556752
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED, Preddie DC.
    Ethn Dis; 2002 Jun 06; 12(4):S3-49-52. PubMed ID: 12477155
    [Abstract] [Full Text] [Related]

  • 27. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P.
    Orv Hetil; 2005 May 01; 146(18):827-31. PubMed ID: 15926627
    [Abstract] [Full Text] [Related]

  • 28. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA.
    Am J Cardiol; 2007 Aug 06; 100(3A):45J-52J. PubMed ID: 17666198
    [Abstract] [Full Text] [Related]

  • 29. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH, Papademetriou V.
    Am Heart J; 2009 Jun 06; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [Abstract] [Full Text] [Related]

  • 30. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M, Deferrari L, Ratto E, Vettoretti S, Parodi D, Deferrari G.
    Ital Heart J Suppl; 2003 Mar 06; 4(3):210-6. PubMed ID: 12784755
    [Abstract] [Full Text] [Related]

  • 31. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.
    Int J Cardiol; 2004 Feb 06; 93(2-3):105-11. PubMed ID: 14975535
    [Abstract] [Full Text] [Related]

  • 32. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 06; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 33. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M.
    Heart Fail Monit; 2002 Jan 06; 2(3):85-7. PubMed ID: 12634889
    [Abstract] [Full Text] [Related]

  • 34. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A, Teo KK.
    Expert Rev Cardiovasc Ther; 2009 Jun 06; 7(6):667-74. PubMed ID: 19505282
    [Abstract] [Full Text] [Related]

  • 35. beta-Blocker therapy in heart failure.
    Doughty RN.
    Heart Fail Monit; 2000 Jun 06; 1(1):2-7. PubMed ID: 12634875
    [Abstract] [Full Text] [Related]

  • 36. [Role of angiotensin-converting enzyme inhibitors in the treatment of heart failure in the 21st century].
    Gibelin P.
    Arch Mal Coeur Vaiss; 2002 Feb 06; 95 Spec 4(5 Spec 4):41-5. PubMed ID: 11933555
    [Abstract] [Full Text] [Related]

  • 37. Renin-angiotensin system modulation: the weight of evidence.
    Brown B, Hall AS.
    Am J Hypertens; 2005 Sep 06; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ, Gums JG.
    Ann Pharmacother; 2005 Mar 06; 39(3):470-80. PubMed ID: 15701766
    [Abstract] [Full Text] [Related]

  • 39. ACE inhibitor use in elderly patients with systolic left ventricular dysfunction: problems and opportunities.
    Pitt B.
    Br J Clin Pract Suppl; 1996 Jul 06; 84():11-6. PubMed ID: 8994996
    [Abstract] [Full Text] [Related]

  • 40. [Converting enzyme inhibitors or AT1 receptor blockers].
    Trevethan Cravioto S.
    Arch Cardiol Mex; 2001 Jul 06; 71 Suppl 1():S171-6. PubMed ID: 11565329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.